EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synthesis and Evaluation of Clinically Translatable Targeted Microbubbles Using a Microfluidic Device for In Vivo Ultrasound Molecular Imaging

Rakesh Bam, Arutselvan Natarajan iD, Farbod Tabesh iD, Ramasamy Paulmurugan iD, Jeremy J Dahl

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24109048 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Rakesh Bam und 4 weiteren Autor:innen. Beteiligte Einrichtung: Canary Center for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, CA 94304, USA. Hauptthemen laut MEDLINE: Receptors, Histamine H3, Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIBIB NIH HHS, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main aim of this study is to synthesize contrast microbubbles (MB) functionalized with engineered protein ligands using a microfluidic device to target breast cancer specific vascular B7-H3 receptor in vivo for diagnostic ultrasound imaging. We used a high-affinity affibody (ABY) selected against human/mouse B7-H3 receptor for engineering targeted MBs (TMBs). We introduced a C-terminal cysteine residue to this ABY ligand for facilitating site-specific conjugation to DSPE-PEG-2K-maleimide (M. Wt = 2.9416 kDa) phospholipid for MB formulation. We optimized the reaction conditions of bioconjugations and applied it for microfluidic based synthesis of TMBs using DSPE-PEG-ABY and DPPC liposomes (5:95 mole %). The binding affinity of TMBs to B7-H3 (MBB7-H3) was tested in vitro in MS1 endothelial cells expressing human B7-H3 (MS1B7-H3) by flow chamber assay, and by ex vivo in the mammary tumors of a transgenic mouse model (FVB/N-Tg (MMTV-PyMT)634Mul/J), expressing murine B7-H3 in the vascular endothelial cells by immunostaining analyses. We successfully optimized the conditions needed for generating TMBs using a microfluidic system. The synthesized MBs showed higher affinity to MS1 cells engineered to express higher level of hB7-H3, and in the endothelial cells of mouse tumor tissue upon injecting TMBs in a live animal. The average number (mean ± SD) of MBB7-H3 binding to MS1B7-H3 cells was estimated to be 354.4 ± 52.3 per field of view (FOV) compared to wild-type control cells (MS1WT; 36.2 ± 7.5/FOV). The non-targeted MBs did not show any selective binding affinity to both the cells (37.7 ± 7.8/FOV for MS1B7-H3 and 28.3 ± 6.7/FOV for MS1WT cells). The fluorescently labeled MBB7-H3 upon systemic injection in vivo co-localized to tumor vessels, expressing B7-H3 receptor, as validated by ex vivo immunofluorescence analyses. We have successfully synthesized a novel MBB7-H3 via microfluidic device, which allows us to produce on demand TMBs for clinical applications. This clinically translatable MBB7-H3 showed significant binding affinity to vascular endothelial cells expressing B7-H3 both in vitro and in vivo, which shows its potential for clinical translation as a molecular ultrasound contrast agent for human applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, Histamine H3Breast NeoplasmsMiceAnimalsHumansFemaleMicrobubblesEndothelial CellsUltrasonographyMice, TransgenicMolecular ImagingContrast MediaLab-On-A-Chip Devices

Stichwörter der Autor:innen

bioconjugationmicrobubblesmicrofluidicsphospholipidsthiol–maleimide

Substanzen

Receptors, Histamine H3Contrast Media

Autor:innen und Institutionen

  • Canary Center for Cancer Early Detection, Department of Radiology, Stanford University School of Medicine, Palo Alto, CA 94304, USA.

ORCID-Profile: Arutselvan Natarajan, Farbod Tabesh, Ramasamy Paulmurugan

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • National Cancer Institute
  • National Institute of Biomedical Imaging and Bioengineering
  • Stanford Cancer Institute and Women’s Cancer Center Innovation Award

Zitieren

APA

Bam, R., Natarajan, A., Tabesh, F., Paulmurugan, R., & Dahl, J. J. (2023). Synthesis and Evaluation of Clinically Translatable Targeted Microbubbles Using a Microfluidic Device for In Vivo Ultrasound Molecular Imaging. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24109048

Vancouver

Bam R, Natarajan A, Tabesh F, Paulmurugan R, Dahl JJ. Synthesis and Evaluation of Clinically Translatable Targeted Microbubbles Using a Microfluidic Device for In Vivo Ultrasound Molecular Imaging. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24109048

BibTeX
@article{Bam2023,
  author = {Bam, Rakesh and Natarajan, Arutselvan and Tabesh, Farbod and Paulmurugan, Ramasamy and Dahl, Jeremy J},
  title = {Synthesis and Evaluation of Clinically Translatable Targeted Microbubbles Using a Microfluidic Device for In Vivo Ultrasound Molecular Imaging},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24109048}
}
Kostenlos starten →